Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04410237 · ClinicalTrials.gov registry record · Early Phase 1
Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System
A Early Phase 1 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 13
- Enrollment target
NCT04410237 is a Early Phase 1 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 13 participants.
The verdict
NCT04410237, a Early Phase 1 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This is an observational pilot study comparing triamcinolone acetonide injections with the investigational Med-jet needle-free drug-delivery system as an alternative to using a conventional syringe and needle in patients with mild-to-moderate psoriasis. There will be five (5) visits necessary for study participation. The hypothesis is that the efficacy, safety, pain tolerance, and quality of life (QoL) metrics of the Med-jet needle-free drug-delivery system will be equal to or superior to that of a conventional syringe and needle.
Interventions
- DEVICE Med-Jet
- OTHER Traditional Syringe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2020-11-04 |
| Est. Completion | 2023-05-19 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04410237
The ClinicalTrials.gov registry entry for NCT04410237 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Med-Jet is the first listed.
NCT04410237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04410237 about?
NCT04410237 is a clinical study titled "Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System". This is an observational pilot study comparing triamcinolone acetonide injections with the investigational Med-jet needle-free drug-delivery system as an alternative to using a conventional syringe and needle in patients with mild-to-moderate psoriasis. There will be five (5) visits necessary for st...
What is the current status of trial NCT04410237?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 13 participants. The study started on 2020-11-04. Estimated completion is 2023-05-19.
What interventions are being tested in trial NCT04410237?
The interventions under investigation include: Med-Jet (DEVICE), Traditional Syringe (OTHER).
Who is sponsoring clinical trial NCT04410237?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.